MCKPF Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 12, 2025
Report Source: 2024 2nd Quarter Report
Mallinckrodt PLC. Stock Analysis MCKPF
Mallinckrodt Plc engages in the development, manufacture, marketing, and distribution of both branded and generic specialty pharmaceutical products. The company is headquartered in Dublin, Dublin. The firm's segments include Specialty Brands and Specialty Generics. The Specialty Brands include specialty pharmaceutical brands. The firm's Specialty Brands segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, and gastrointestinal products. Its Specialty Generics segment includes specialty generic drugs and active pharmaceutical ingredients (APIs). Its product portfolio includes Acthar Gel, INOmax, StrataGraft, Terlivaz, and Amitiza.
Read More Mallinckrodt PLC (MCKPF) Chart
Key Statistics of Mallinckrodt PLC (MCKPF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.12Volume
-P/E Ratio (TTM)
-Market Cap
1.60MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Mallinckrodt PLC (MCKPF)
FAQ's for Mallinckrodt PLC (MCKPF)
- According to Musaffa’s Shariah screening methodology, Mallinckrodt PLC (MCKPF) is currently classified as NOT HALAL as of March 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.